The department has participated in research projects, made a lot of researches and published them in many prominent scientific journals:
A research on the medicine for lupus and it was published in Current Rheumatology Reviews journal in 2012.
A chapter in Skills in Rheumatology book under the title of the curing medicines for the Rheumatic Diseases was published in 2015. The publisher was Elsevier.
A research on the Epilepsy under the title "دراسةتاثيربعضالأدويةالمعدلةللمناعةعلىنموذجتجريبيللصرعالناجمعناستخدام (الليثيوم-بيلوكاربين) قيذكورالجرذانالبالغة". The piece was published in Brain Research journal in 2016. The results of the research were presented in a scientific conference about the Epilepsy in Rome, Italy on November 21-23, 2016, and in Paris, France on August 6-8, 2017.
A research on the Anti-Rheumatic Diseases Biological Medicines and it was published in EC Pharmacology and Toxicology journal in 2017.
A research on the Osteoporosis under the title " تأثيرمثبطاتمضخةالبروتونعلىكثافةالعظامفيالجرذان” in publication. The results of the research were presented in a scientific conference in Rome, Italy on November 24-26, 2016.
A research on Kidney Protection for Diabetes Patients, under the title of "دراسةمقارنةللتاثيرالوقائيعليالكلىلكلمنكاناجلفلوزينوتيلميسارتانفينموذجلإصابةالكلىفيالجرذانالمصابةبمرضالبولالسكري". It was published in J Nephrol Renal Ther, a specialized journal for kidney diseases, in 2016.
The results of the research were presented in a scientific conference about Diabetes in Miami, USA on January 22-25, 2017.
A research on the Epilepsy under the title "دراسةتاثيرفيتاميندالواقيللأعصابوتداخلهمععقارلاموتريجينعلىنموذجتجريبيللصرعالناجمعناستخدام (الليثيوم-بيلوكاربين ) فيالجرذان". It was publish in Naunyn-Schmiedeberg's Arch, a specialized journal about medicines, in 2017.
A research on the Epilepsy under the title "دراسةتاثيرفيتاميندمععقارلاموتريجينفيمنعالصرعوتحسينالإدراكفينموذجللصرعالناجمعناستخدامبنتيلينتترازولفيالجرذان". It was publish in Brain Research journal in 2017.
A research titled "نمطاستخدامالادويهلعلاجالتهاباتالجهازالتنفسيالعلويفيطبالأطفالفىمستشفىجامعىفىنيودلهى". It was published in Bulletin of Environment, Pharmacology and Life Sciences journal in 2016.
A research titled " تقييمممارساتوصفالأدويةفيالمستشفياتالخاصةوالعامةفيمكةالمكرمة،المملكةالعربيةالسعودية “. It was published in African Journal of Pharmacy and Pharmacology in 2015.
A research on Phytosterols titled كعاملمضادللسرطانالطبيعي: الوضعالحاليوالمنظورالمستقبلي . It was published in Biomedicine & Pharmacotherapy journal in 2017.
An intended for publication research titled "تأثيرمستخلصأوراقنبتتيالعتموالعرعرالسرويعلىالتهابالمثانةالخلاليالناتجعنالتوتروالاجهادفيالفئرانالمخبرية “ in 2017.
A research titledاءثيرالفينولاتكهرموناتاستروجينيةطبيعيةوتعويضيةودراسةالتراكيبالبناءةللمركباتوالتحامالجزيءي . It was published in the Molecules journal in 2016.
A research on the natural phenolic compounds as anti-oxidants and proving their impact in the experimental animals. A published research in PeerJ Journal in 2016.
A research on the composition of the natural compound of the Pulicaria flower as antibiotics and anti-cancerous cells. Biodiversity 2017
A research on the natural sulfuric compounds and their impact on the cancerous cells.(breasts - colon - liver) and as natural broad-spectrum antibiotics. It was published in Journal of Pharmaceutical Biology in 2016.
A research on identifying the natural compound of biological impact using chromatography HPLC and a spectrometer. It was published in Botanical Science in 2017.
A research sent for publishing on the impact of the natural compounds in curing Diabetes and a detailed explanation for their impact.
A research intended for publication in the impact of the phenols on the cirrhosis of the liver and a detailed explanation for their impact.
** For research cooperation with the Department of Pharmacology and Toxicology at the College of Medicine, please click here.
Loading
English
English
Arabic
Accessibility Tools
Oversize Widget
Accessibility Modes00
Epilepsy Safe Mode
Dampens color and removes blinks
This mode enables people with epilepsy to use the website safely by eliminating the risk of seizures that result from flashing or blinking animations and risky color combinations.
Visually Impaired Mode
Improves websites visuals
This mode adjusts the website for the convenience of users with visual impairments such as Degrading Eyesight, Tunnel Vision, Cataract, Glaucoma, and others.
Cognitive Disability Mode
Helps to focus on specific content
This mode provides different assistive options to help users with cognitive impairments such as Dyslexia, Autism, CVA, and others, to focus on the essential elements of the website more easily.
Motor Impaired Mode
Allows using the website with a keyboard
This mode enables people with motor impairments to operate the website by using the keyboard Tab, Shift+Tab, and the Enter keys. Users can also use speech recognition software such as Dragon Naturally Speaking.
Colorblind Mode
Adjusts the website for colorblind users
This mode adjusts the website for colorblind users such as Protanopia, Deuteranopia, Tritanopia, and others. It also helps users with Cataracts and Glaucoma.
Dyslexia Friendly Mode
Helps users with Dyslexia
This mode adjusts the website to be easier to read for people with Dyslexia, which is a reading disability characterized by trouble with reading despite normal intelligence.
ADHD Friendly Mode
Reduces distractions and improve focus
This mode helps users with ADHD and Neurodevelopmental disorders to read, browse, and focus on the main website elements more easily while significantly reducing distractions.
Blindness Mode
Allows using the site with your screen-reader
This mode configures the website to be compatible with screen-readers such as JAWS, NVDA, VoiceOver, and TalkBack. A screen-reader is software for blind users that is installed on a computer and smartphone, and websites must be compatible with it.